Payden & Rygel Investment Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$6.35M Buy
32,300
+29,700
+1,142% +$6.14M 0.51% 68
2024
Q1
$560K Buy
+2,600
New +$546K 0.03% 103
2023
Q3
$521K Buy
+2,600
New +$517K 0.04% 111

Other funds holding CME

Payden & Rygel Investment Group's CME Position: Q2 2024 in Review

Payden & Rygel Investment Group increased its CME Group (CME) stake by 1,142% in Q2 2024, buying an estimated $6.14M and bringing the position to 32,300 shares worth $6.35M. The position accounts for 0.51% of the portfolio, ranked #68.

Payden & Rygel Investment Group first reported a position in CME in Q3 2023 and has held it in 3 quarters since. 1,377 funds tracked by Wall St. Rank hold CME as of Q2 2024.

  • Payden & Rygel Investment Group held 32,300 shares of CME Group worth $6.35M as of Q2 2024.
  • Payden & Rygel Investment Group bought 29,700 CME Group shares in Q2 2024, an estimated $6.14M.
  • CME Group made up 0.51% of Payden & Rygel Investment Group's portfolio in Q2 2024, its #68 holding.
  • Payden & Rygel Investment Group first reported a position in CME Group in Q3 2023 and has held it in 3 quarters since.
  • 1,377 funds tracked by Wall St. Rank held CME Group as of Q2 2024.

Based on Payden & Rygel Investment Group's 13F filing for Q2 2024, filed 12 Aug 2024.